{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:01:43Z","timestamp":1780452103260,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00415-011-6027-8","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T11:32:26Z","timestamp":1301743946000},"page":"1820-1826","source":"Crossref","is-referenced-by-count":23,"title":["High disease impact of myotonic dystrophy type 2 on physical and mental functioning"],"prefix":"10.1007","volume":"258","author":[{"given":"Alide A.","family":"Tieleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Jenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke S.","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Borm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel G. M.","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,3]]},"reference":[{"key":"6027_CR1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198527824.001.0001","volume-title":"Myotonic dystrophy: present management, future therapy","author":"PS Harper","year":"2004","unstructured":"Harper PS, van Engelen BGM, Eymard B et al (2004) Myotonic dystrophy: present management, future therapy. Oxford University Press, New York"},{"key":"6027_CR2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.20800","volume":"6","author":"G Meola","year":"2007","unstructured":"Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 6:294\u2013306","journal-title":"Muscle Nerve"},{"key":"6027_CR3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nmd.2008.05.010","volume":"18","author":"AA Tieleman","year":"2008","unstructured":"Tieleman AA, van Vliet J, Jansen JB et al (2008) Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord 18:646\u2013649","journal-title":"Neuromuscul Disord"},{"key":"6027_CR4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML et al (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864\u2013867","journal-title":"Science"},{"key":"6027_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","volume":"16","author":"B Udd","year":"2006","unstructured":"Udd B, Meola G, Krahe R et al (2006) 140th ENMC international workshop: myotonic dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 16:403\u2013413","journal-title":"Neuromuscul Disord"},{"key":"6027_CR6","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/archneur.61.12.1938","volume":"61","author":"A George","year":"2004","unstructured":"George A, Schneider-Gold C, Zier S et al (2004) Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 61:1938\u20131942","journal-title":"Arch Neurol"},{"key":"6027_CR7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp.2008.158261","volume":"81","author":"C Turner","year":"2010","unstructured":"Turner C, Hilton-Jones D (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81:358\u2013367","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6027_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.apmr.2007.08.153","volume":"89","author":"MP Jensen","year":"2008","unstructured":"Jensen MP, Hoffman AJ, Stoelb BL et al (2008) Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 89:320\u2013328","journal-title":"Arch Phys Med Rehabil"},{"key":"6027_CR9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.apmr.2004.11.028","volume":"86","author":"MP Jensen","year":"2005","unstructured":"Jensen MP, Abresch RT, Carter GT et al (2005) Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 86:1155\u20131163","journal-title":"Arch Phys Med Rehabil"},{"key":"6027_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00415-009-5049-y","volume":"256","author":"J Trip","year":"2009","unstructured":"Trip J, de Vries J, Drost G et al (2009) Health status in non-dystrophic myotonias: close relation with pain and fatigue. J Neurol 256:939\u2013947","journal-title":"J Neurol"},{"key":"6027_CR11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/jnnp.2004.050005","volume":"76","author":"JS Kalkman","year":"2005","unstructured":"Kalkman JS, Schillings ML, van der Werf SP et al (2005) Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 76:1406\u20131409","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6027_CR12","first-page":"353","volume-title":"Assessment in behavioral medicine","author":"J Vries De","year":"2001","unstructured":"De Vries J (2001) Quality of life assessment. In: Vingerhoets AJJM (ed) Assessment in behavioral medicine. Brunner-Routledge, Hove, pp 353\u2013370"},{"key":"6027_CR13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-4356(98)00083-3","volume":"51","author":"AK Wagner","year":"1998","unstructured":"Wagner AK, Gandek B, Aaronson NK et al (1998) Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA project. International quality of life assessment. J Clin Epidemiol 51:925\u2013932","journal-title":"J Clin Epidemiol"},{"key":"6027_CR14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0895-4356(98)00086-9","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE Jr (1998) Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International quality of life assessment. J Clin Epidemiol 51:953\u2013959","journal-title":"J Clin Epidemiol"},{"key":"6027_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","volume":"51","author":"NK Aaronson","year":"1998","unstructured":"Aaronson NK, Muller M, Cohen PD et al (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055\u20131068","journal-title":"J Clin Epidemiol"},{"key":"6027_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nmd.2006.09.017","volume":"17","author":"BG Engelen van","year":"2007","unstructured":"van Engelen BG, van Veenendaal H, van Doorn PA et al (2007) The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord 17:33\u201337","journal-title":"Neuromuscul Disord"},{"key":"6027_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30:473\u2013483","journal-title":"Med Care"},{"key":"6027_CR18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp.2009.183863","volume":"81","author":"R Sadjadi","year":"2010","unstructured":"Sadjadi R, Rose MR, Muscle Study Group (2010) What determines quality of life in inclusion body myositis? J Neurol Neurosurg Psychiatry 81:1164\u20131166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6027_CR19","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.WNL.0000142597.69707.78","volume":"63","author":"ML Hagemans","year":"2004","unstructured":"Hagemans ML, Janssens AC, Winkel LP et al (2004) Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63:1688\u20131692","journal-title":"Neurology"},{"key":"6027_CR20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0304-3959(87)90027-3","volume":"30","author":"K Vanderiet","year":"1987","unstructured":"Vanderiet K, Adriaensen H, Carton H et al (1987) The McGill pain questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity. Pain 30:395\u2013408","journal-title":"Pain"},{"key":"6027_CR21","first-page":"669","volume":"139","author":"WA Kloot Van der","year":"1995","unstructured":"Van der Kloot WA, Oostendorp RA, van der Meij J et al (1995) The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire. Ned Tijdschr Geneeskd 139:669\u2013673","journal-title":"Ned Tijdschr Geneeskd"},{"key":"6027_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","volume":"38","author":"JH Vercoulen","year":"1994","unstructured":"Vercoulen JH, Swanink CM, Fennis JF et al (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383\u2013392","journal-title":"J Psychosom Res"},{"key":"6027_CR23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(00)04198-2","volume":"17","author":"JB Prins","year":"2001","unstructured":"Prins JB, Bleijenberg G, Bazelmans E et al (2001) Cognitive behavior therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 17:841\u2013847","journal-title":"Lancet"},{"key":"6027_CR24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.59.1.84","volume":"59","author":"ISJ Merkies","year":"2002","unstructured":"Merkies ISJ, Schmitz PIM, van der Meche FGA et al (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84\u201391","journal-title":"Neurology"},{"key":"6027_CR25","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0277-9536(99)00412-8","volume":"50","author":"CS Carver","year":"2000","unstructured":"Carver CS, Scheier MF (2000) Scaling back goals and recalibration of the affect system are processes in normal adaptive self-regulation: understanding \u2018response shift\u2019 phenomena. Soc Sci Med 50:1715\u20131722","journal-title":"Soc Sci Med"},{"key":"6027_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.87.1.38","volume":"87","author":"GI Kempen","year":"1997","unstructured":"Kempen GI, Ormel J, Brilman EI et al (1997) Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health 87:38\u201344","journal-title":"Am J Public Health"},{"key":"6027_CR27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","volume":"13","author":"G Meola","year":"2003","unstructured":"Meola G, Sansone V, Perani D et al (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2). Neuromuscul Disord 13:813\u2013821","journal-title":"Neuromuscul Disord"},{"key":"6027_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.53.5.1042","volume":"53","author":"G Meola","year":"1999","unstructured":"Meola G, Sansone V, Perani D et al (1999) Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 53:1042\u20131050","journal-title":"Neurology"},{"key":"6027_CR29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.20800","volume":"36","author":"G Meola","year":"2007","unstructured":"Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36:294\u2013306","journal-title":"Muscle Nerve"},{"key":"6027_CR30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/pubmed\/21.4.372","volume":"21","author":"C Jenkinson","year":"1999","unstructured":"Jenkinson C (1999) Comparison of UK and US methods for weighting and scoring the SF-36 summary measures. J Public Health Med 21:372\u2013376","journal-title":"J Public Health Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6027-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T17:53:50Z","timestamp":1712339630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,3]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["6027"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6027-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,3]]}}}